I-β-D-Ribofuranose 1-Acetate 2,3,5-Tribenzoate CAS 6974-32-9 Assay ≥99.0% (HPLC) Clofarabine Intermediate High Purity

Inkcazelo emfutshane:

Igama: β-D-Ribofuranose 1-Acetate 2,3,5-Tribenzoate

CAS: 6974-32-9

Imbonakalo: Umgubo weCrystalline oMhlophe okanye oMhlophe

Uvavanyo: ≥99.0% (HPLC)

Phakathi kweClofarabine (CAS: 123318-82-1) kunyango lwaBantwana abane-Acute Lymphoblastic Leukemia (ALL)

Inquiry: alvin@ruifuchem.com

Thumela i-imeyile kuthi

Iinkcukacha zeMveliso

Iimveliso ezinxulumeneyo

Iithegi zeMveliso

Inkcazo:

Ubonelelo ngezoRhwebo lweClofarabine oluNxulumene neMiphakathi:
I-Clofarabine CAS: 123318-82-1
I-2-Deoxy-2-fluoro-1,3,5-tri-O-benzoyl-α-D-arabinofuranose CAS: 97614-43-2
I-β-D-Ribofuranose 1-Acetate 2,3,5-Tribenzoate CAS: 6974-32-9
1,3,5-Tri-O-benzoyl-D-Ribofuranose CAS: 22224-41-5
2,6-Dichloropurine CAS: 5451-40-1

Iipropati zeMichiza:

Igama leMchiza	I-β-D-Ribofuranose 1-Acetate 2,3,5-Tribenzoate
Izithethantonye	1-O-Acetyl-2,3,5-tri-O-benzoyl-β-D-Ribofuranose
Inombolo yeCAS	6974-32-9
Inombolo yeCAT	RF-PI222
Ubume beStokhwe	Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni
Ifomula yeemolekyuli	C28H24O9
Ubunzima beMolekyuli	504.49
Uphawu	Ruifu Chemical

Iinkcukacha:

Into	Iinkcukacha
Imbonakalo	Umgubo weCrystalline oMhlophe okanye oMhlophe
Indlela yoVavanyo / yoHlahlelo	≥99.0% (HPLC)
Indawo yokunyibilika	126.0 ~ 133.0℃
Ilahleko ekomisweni	≤0.50%
Intsalela kwi-Ignition	≤0.50%
Ukungcola ngokupheleleyo	≤1.00%
Iintsimbi ezinzima	≤20ppm
Umgangatho woVavanyo	Umgangatho woShishino
Ukusetyenziswa	I-Pharmaceutical Intermediate yeClofarabine CAS: 123318-82-1

Ukupakishwa kunye noGcino:

Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, igubu lekhadibhodi, 25kg/Igubu, okanye ngokwemfuno yomthengi.

Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ekukhanyeni, ukufuma kunye nokuhlaselwa zizinambuzane.

Izinto eziluncedo:

FAQ:

Isicelo:

I-β-D-Ribofuranose 1-Acetate 2,3,5-Tribenzoate (CAS 6974-32-9) yindawo ephakathi (i-Clofarabine CAS: 123318-82-1).I-Clofarabine (i-CAS: i-123318-82-1) iyinoveli ye-purine nucleoside anticancer drugs iphuhliswe ngempumelelo yi-Top10 biopharmaceutical company ye-United States-Genzyme Corporation kunye namagama orhwebo athi "Clofarabine".NgoDisemba 28, i-2004 i-US yokutya kunye noLawulo lweDrugs (i-FDA) isetyenziswe ngokukhawuleza ukuvunywa kwe-clofarabine kwisicelo kubantwana abane-refractory okanye i-relapsed acute lymphocytic leukemia (YONKE);inokusebenza okugqwesileyo kunyango lwe-leukemia ngokunyamezela kakuhle kwaye akukho ziziphumo ezibi ezingalindelekanga.Inokulawulwa nokuba ifakwe emithanjeni okanye ilawulwe ngomlomo.Eli chiza yimveliso yokuqala evunyiweyo ukuba inikezelwe kunyango lwe-leukemia yabantwana kwiminyaka engaphezu kweshumi.